Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Janssen Pharmaceutica presents new matrix metalloproteinase inhibitors

June 21, 2012

Japanese group patents novel DCP-LA enantiomers

June 21, 2012

New potassium channel blockers designed at Pierre Fabre

June 21, 2012

Spanish scientists develop new agents for neurodegenerative diseases

June 21, 2012

Merck KGaA prepares novel protein kinase inhibitors

June 21, 2012

Researchers at Leo Pharma synthesize novel CaSR agonists

June 21, 2012

Novel candidate hepatitis therapies divulged by Gilead Sciences

June 20, 2012

Team in Israel patents new treatments for genetic disorders

June 20, 2012

French center synthesizes new agents for bone disorders

June 20, 2012

Jenrin Discovery develops new agents targeting CB1 receptor

June 20, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...